Skip to content

Abbott ABT Other intangible assets—net

Other intangible assets—net at other companies

Johnson & Johnson logo
Johnson & JohnsonJNJ
$49.06B+33.5%
Boston Scientific logo
Boston ScientificBSX
$7.06B+7.5%
Edwards Lifesciences logo
Edwards LifesciencesEW
$1.23B+4.5%
DexCom logo
DexComDXCM
Medtronic logo
MedtronicMDT
Medline, Inc.
 logo
Medline, Inc. MDLN

Other financials

Income statement

See full
Revenue$11.2B+7.8%
Gross profit$6.3B+6.5%
Operating income$1.3B-20.6%
Net income$1.1B-18.7%
EPS (diluted)$0.61-19.7%

Balance sheet

See full
Cash & equivalents$6.8B+4.2%
Total debt$34.0B+157%
Total equity$52.1B+6.7%
Total assets$110.43B+35.6%

Cash flow

See full
Operating cash flow$1.3B-7.2%
CapEx$399.0M-17.6%
Free cash flow$916.0M-1.8%

Valuation

See full
Market cap$154.15B-22.5%
Enterprise value$181.39B-13.1%
P/E24.6×+9.8×
P/S3.4×-1.3×

Profitability

See full
Gross margin56.3%+0.4pp
Operating margin17.1%+0.2pp
Net margin13.9%-18.0pp

Returns & leverage

See full
Return on equity12.4%-18.4pp
Debt / equity0.7×+0.4×
Current ratio1.4×-0.4×

Where this comes from

Reported directly by Abbott in its filing.

Tagged under the XBRL concept us-gaap:IntangibleAssetsNetExcludingGoodwill.

The official record: Abbott’s 10-Q, filed April 29, 2026, on SEC EDGAR. View the filing →

Ask your AI about Abbott's other intangible assets—net.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Abbott's other intangible assets—net?
Abbott (ABT) reported other intangible assets—net of $17.88B in Q1 2026.
How has Abbott's other intangible assets—net changed year-over-year?
Abbott's other intangible assets—net increased by 185.5% year-over-year, from $6.26B to $17.88B.
What is the long-term trend for Abbott's other intangible assets—net?
Over 5 years (2020 to 2025), Abbott's other intangible assets—net has grown at a -17.9% compound annual growth rate (CAGR), from $14.78B to $5.53B.